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In Brief
In the ascidian Ciona intestinalis, nascent
heart progenitor cells inherit an adherent
membrane associated with elevated
levels of FGFR signaling. Cota and
Davidson now explain the basis for this
observation, showing that adhesion, via
effects on Caveolin-rich membrane
domains, limits FGFR internalization,
leading to receptor enrichment at the
adherent membrane.
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In response to microenvironmental cues, embryonic
cells form adhesive signaling compartments that in-
fluence survival and patterning. Dividing cells detach
from the surrounding matrix and initiate extensive
membrane remodeling, but the in vivo impact of
mitosis on adhesion-dependent signaling remains
poorly characterized.We investigate in vivo signaling
dynamics using the invertebrate chordate, Ciona
intestinalis. InCiona, matrix adhesion polarizes fibro-
blast growth factor (FGF)-dependent heart progeni-
tor induction. Here, we show that adhesion inhibits
mitotic FGF receptor internalization, leading to re-
ceptor enrichment along adherent membranes. Tar-
geted disruption of matrix adhesion promotes
uniform FGF receptor internalization and degrada-
tion while enhanced adhesion suppresses degrada-
tion. Chimeric analysis indicates that integrin b
chain-specific impacts on induction are dictated by
distinct internalizationmotifs.We also found thatma-
trix adhesion impacts receptor enrichment through
Caveolin-rich membrane domains. These results
redefine the relationship between cell division and
adhesive signaling, revealing how mitotic membrane
turnover orchestrates adhesion-dependent signal
polarization.
INTRODUCTION
Embryonic cells interpret a complex suite of cues in order to
respond appropriately to their dynamic microenvironment.
Microenvironmental cues include transmembrane proteins on
adjacent cells, paracrine signals, and extracellular matrix. Cells
adhere to the matrix through Integrin receptors. Once bound, In-
tegrins recruit large cytoplasmic complexes capable of inte-
grating diverse extracellular inputs (Streuli and Akhtar, 2009;
Hu and Luo, 2013; Ivaska and Heino, 2011; Moser et al., 2009).
The impact of matrix adhesion on cellular information processing
has been studied primarily in four contexts. In migrating cells,
matrix adhesion provides mechanical traction and coordinates
cell polarization including localized enrichment of chemosensory
receptors (Caswell and Norman, 2008; Huttenlocher and Hor-Developmenwitz, 2011). In pre-cancerous cells, escape from adhesion-
dependent growth regulation results in ectopic signal activation
and uncontrolled proliferation (Guadamillas et al., 2011). During
mitosis, matrix adhesion contributes to spindle alignment, im-
pacting the orientation and symmetry of division (Toyoshima
and Nishida, 2007). In vitro studies have also revealed that matrix
adhesion can profoundly influence growth factor signaling
thereby impacting stem cell fate specification (Dave et al.,
2014; Engler et al., 2006; Reilly and Engler, 2010; Yim and
Sheetz, 2012). In contrast, relatively few studies have focused
on the role of matrix adhesion in embryonic cell specification
(Miller and Davidson., 2013; Brunet et al., 2013; Farge, 2011;
Fonar et al., 2011; Martin-Bermudo, 2000; Norton et al., 2013).
Thus, the dynamic, in vivo impact of matrix adhesion on embry-
onic cell fate decisions remains poorly characterized.
The invertebrate chordate Ciona intestinalis represents a valu-
able model organism for studying the in vivo cell biology of fate
specification. Due to their close phylogenetic relationship, Ciona
and vertebrate embryos share unique, derived developmental
features (Davidson, 2007; Lemaire, 2011). In comparison with
their vertebrate cousins, Ciona embryos have greatly reduced
genomic complexity (Cota et al., 2014; Dehal et al., 2002). Ciona
embryos also develop with extremely low cell numbers, facili-
tating high-resolution in vivo analysis (Stolfi and Christiaen,
2012). The extreme cellular simplicity of Ciona embryogenesis
is exemplified by the heart lineage (Figure 1A). The Ciona heart
can be traced back to four cardiac founder cells (the B7.5 line-
age; Davidson and Levine, 2003). Each bilateral founder cell
pair divides asymmetrically to produce bilateral quartets con-
taining two smaller anterior daughters and two larger posterior
daughters. Within each quartet, FGF signaling differentially in-
duces Mitogen Activated Protein Kinase (MAPK)-dependent
heart progenitor specification in the smaller daughter cells (the
Trunk Ventral Cells; Davidson et al., 2006). Previous work has re-
vealed a key role for matrix adhesion in differential heart progen-
itor induction (Figure 1A0). Prior to division, founder cells exhibit a
broad domain of matrix adhesion along the ventral, epidermal
boundary (Norton et al., 2013). This adherent domain correlates
with a broad region of FGF receptor activation. Invasive protru-
sions associated with mitosis appear to anchor the ventral
founder cell membrane, preserving a restricted domain of adhe-
sion and associated FGFR activity during mitotic rounding
(Cooley et al., 2011; Norton et al., 2013). Following division,
nascent heart progenitors inherit the adherent signal-enriched
ventral membrane. Thus, although dividing founder cells are
exposed uniformly to FGF (Cooley et al., 2011), sustained matrixtal Cell 34, 505–519, September 14, 2015 ª2015 Elsevier Inc. 505
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Figure 1. Polarized Distribution of FGFR:Venus during Founder Cell Division
(A) Position of cardiac founder lineage cells in Ciona embryos, ventral views for early stages, lateral view at stage 23.
(A0) Model of differential induction in an individual founder cell, lateral view, based on previous data (Beh et al., 2007; Cooley et al., 2011; Davidson et al., 2005;
Norton et al., 2013).
(B–D0 0) Lateral sections and accompanying diagrams of Mesp>FGFR:Venus staining in founder lineage cells (Hotta stages 13–15 as indicated at the top of each
column) stained as indicated; dashed lines indicate phalloidin stained cell membranes (red) or epidermal border (white, Epi). Because phalloidin staining obscures
FGFR localization, this channel is not shown. Membrane-associated (arrows) and intracellular (arrowheads) FGFR:Venus foci are indicated.
(C0) Measurements of FGFR:Venus staining along the membrane were used to determine a Ventral/Dorsal (V/D) ratio. D, dorsal; V, ventral; HP, heart progenitor;
ATM, anterior tail muscle cell. Scale bars are indicated in micrometers. Embryos oriented anterior to the left.
See also Figure S1.
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adhesion along the ventral membrane potentiates differential in-
duction (Norton et al., 2013). Although we have previously
demonstrated an essential role for matrix adhesion in heart pro-
genitor induction (Norton et al., 2013), the precise molecular link
between adhesion and inductive signaling has remained unre-
solved. Here, we provide evidence that matrix-adhesion impacts
membrane dynamics, polarizing FGF receptor distribution to
drive differential heart progenitor induction.
RESULTS
FGF Receptor Is Enriched along the Ventral, Adherent
Membrane during Founder Cell Mitosis
We first investigated the proximal mechanism underlying differ-
ential induction in response to uniform FGF exposure. The
most straightforward hypothesis for differential induction is
polarized FGF receptor distribution. We therefore assayed
FGFR distribution by expressing fluorescently tagged FGFR
(FGFR:Venus) specifically in the Ciona founder cell lineage using
the well-characterized Mesp enhancer (Mesp>FGFR:Venus; Da-
vidson et al., 2006). To alleviate concerns regarding the potential
impact of this construct on induction, we co-transfected em-
bryos with Mesp>GFP and FoxF>RFP reporter constructs (Fig-
ures 1A and S1A). FoxF>RFP reporter activity within Mesp>GFP
labeled founder lineage cells represents a well-established
assay for heart progenitor specification (Figures 1A and S1A;
Beh et al., 2007; Cooley et al., 2011; Norton et al., 2013). In
wild-type embryos, heart progenitors express FoxF>RFP shortly
after founder cell division (Cooley et al., 2011) and migrate
anteriorly into the head (Figure S1B; Beh et al., 2007). Co-trans-
fection with Mesp>FGFR:Venus had no discernable impact on
induction or migration (Figure S1C). We therefore began to
employMesp>FGFR:Venus to examine FGFR distribution during
founder cell mitosis. Transgenic Mesp>FGFR:Venus embryos
were collected at 15-min intervals spanning mitosis and co-
stained with a chromatin marker (DRAQ5) to facilitate precise
mitotic staging (Figures 1B–1D; Hotta et al., 2007). In pre-mitotic
founder cells (stage 13), FGFR:Venus is enriched along both
ventral and lateral membranes (Figure 1B). During mitosis (stage
14), FGFR:Venus accumulates in large intra-cellular foci (arrow-
heads, Figure 1C), suggesting that FGF receptors are internal-
ized during pervasive membrane turnover characteristic of
dividing cells (Boucrot and Kirchhausen, 2007; Fu¨rthauer and
Gonza´lez-Gaita´n, 2009; McKay and Burgess, 2011; Tacheva-
Grigorova et al., 2013). Notably, redistribution of FGFR in mitotic
founder cells appears to be highly polarized. FGFR:Venus stain-
ing in intracellular foci or along the plasma membrane was
dramatically enriched on the ventral side (VTotal/DTotal = 3.60 ±
0.63; Figure 1C0). Because signaling is terminated in more cen-
tral, mature endocytic compartments (Goh and Sorkin, 2013),
we focused further analysis on FGFR:Venus staining proximal
to the plasma membrane. Quantitative analysis comparing fluo-
rescence in ventral versus dorsal membrane regions confirmed
consistent and significant ventral enrichment during mitosis
(VMem/DMem = 4.44 ± 0.84, Figure 1C
0). Consistent ventral enrich-
ment of FGFR:Venus also occurred internally (VInt/DInt = 2.84 ±
0.49). Following division, FGFR is highly concentrated in the
heart progenitor lineage, presumably due to differential inheri-
tance of receptor-enriched plasma membrane or associatedDevelopmenvesicles (Figure 1D). Thus, our data support a model in which dif-
ferential induction is driven by unequal receptor distribution dur-
ing founder cell mitosis.
FGF Signaling Is Not Required for Mitotic FGF Receptor
Enrichment
Receptor internalization and trafficking is often modulated by
ligand binding and downstream pathway activation (Goh and
Sorkin, 2013). We were therefore interested in examining
whether FGF signaling recursively regulates FGFR distribution.
To investigate this hypothesis, we blocked FGF signaling
through targeted expression of a Venus-tagged dominant-nega-
tive FGFR fusion protein (Mesp>FGFRDN:Venus; Davidson et al.,
2006). Previous work has shown that expression of FGFRDN:
Venus in founder cells completely blocks heart progenitor induc-
tion (Davidson et al., 2006). Analysis of FGFRDN:Venus distribu-
tion indicated that loss of FGF signaling had no discernable
impact on FGFR distribution (Figure S1). FGFRDN:Venus was en-
riched along adherent membranes during mitosis and robustly
partitioned in adherent daughter cells following mitosis (cf. Fig-
ures S1D–S1F to Figures 1B–1D). Intriguingly, transfection with
FGFRDN:Venus appeared to disrupt the unequal division of
founder cells (Figure S1F). To verify this observation, we
measured the volume of founder cell daughters in control and
FGFRDN:Venus transgenic embryos and calculated the volume
ratio between the smallest and largest pairs. Control founder
cells consistently divide in a highly unequal fashion, as indicated
by a median volume ratio of 2.35. In contrast, FGFRDN:Venus
transgenic founder cells divide equally, with a median volume
ration of 1.35 (Figure S1G). Thus, FGF signaling does not
appear to impact FGFR enrichment but does play an unantici-
pated role in directing the plane of founder cell division. Further-
more, these data indicate that cellular anisotropies associated
with unequal division (including displacement of themitotic spin-
dle and cytokinetic ring) are not required for polarized FGFR
enrichment.
Matrix Adhesion Is Necessary and Sufficient for Mitotic
FGF Receptor Enrichment
The spatiotemporal pattern of FGFR:Venus distribution mirrors
the gradual constriction of matrix adhesion along the epidermal
boundary previously observed during mitotic rounding (Fig-
ure 1A; Norton et al., 2013). Additionally, we previously found
that regional matrix adhesion mediates differential induction
(Norton et al., 2013). We therefore hypothesized that adhesion
impacts mitotic FGFR distribution, promoting receptor enrich-
ment along the presumptive heart progenitor membrane, a pro-
cess we term ‘‘adhesive enrichment.’’ To test this hypothesis, we
disrupted adhesion using a dominant-negative Rap construct
(Mesp>RapS17N) and examined the effect on FGFR:Venus local-
ization. Rap functions as a molecular switch upstream of Integrin
activation (Boettner and Van Aelst, 2009) and targeted expres-
sion of RapS17N disrupts heart progenitor induction specifically
through its impact on matrix adhesion (Figure 2A; Norton et al.,
2013). As previously observed, the majority of RapS17N founder
cells appear completely detached, exhibiting a rounded mor-
phology and dorsal displacement away from the epidermis
(cf. Figure 2B versus Figure 2C). Occasionally, RapS17N founder
cells maintain limited adhesion along the epidermal boundary,tal Cell 34, 505–519, September 14, 2015 ª2015 Elsevier Inc. 507
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Figure 2. Matrix Adhesion Is Necessary and Sufficient for FGF Receptor Enrichment
(A–A0 0) Illustrations showing (A and A0) Intb2-specific rescue of adhesion/heart progenitor induction in transgenic RapS17N founder lineage cells and (A0 0) increased
adhesion and heart progenitor induction associatedwith constitutive Rap activation (RapG12V) based on previous data (Norton et al., 2013). Adhesive foci (yellow).
Heart progenitor induction indicated by red nuclei.
(B–G0 0) Lateral sections and accompanying diagrams of FGFR:Venus distribution in mitotic founder cells co-transfected as labeled. Membrane-associated
FGFR:Venus foci are indicated (arrows). Dashed lines indicate phalloidin stained cell membranes (red) or epidermal border (white, Epi).
(H) Quantitation of FGFR:Venus staining along the periphery of transgenic LacZ control and RapG12V founder cells. *p = 0.0007 for LacZ versus RapG12V.
Scale bars are indicated in micrometers. Embryos are oriented anterior to the left.resulting in less severe displacement (Figure 2D; Norton et al.,
2013). In fully detached founder cells, FGFR:Venus is uniformly
internalized and appears to undergo subsequent degradation
during mitosis. Thus, by metaphase FGFR:Venus staining was
largely absent (Figure 2C). In partially detached founder cells,
FGFR:Venus was present in both intracellular foci and along
persistent adherent membranes (arrows, Figure 2D). These
data indicate that matrix adhesion is required for localized
FGFR enrichment in dividing founder cells, possibly by inhibiting
internalization or by promoting recycling. Additionally, these
adhesion-dependent modifications in trafficking appear to
regionally suppress FGFR degradation.508 Developmental Cell 34, 505–519, September 14, 2015 ª2015 ElsBecause Rap GTPases perform multiple regulatory functions
(Boettner and Van Aelst, 2009), we focused on determining
whether RapS17N specifically impacts mitotic FGFR enrichment
by perturbingmatrix adhesion. Mirroring previous studies (Norton
et al., 2013), we examined whether restoration of matrix adhesion
was sufficient to rescue FGFR enrichment in a transgenic
Mesp>RapS17N background. Co-expression of Ciona Integrin-b1
(Mesp>Intb1) doesnot restoreadhesionor induction (as illustrated
in Figure 2A andNorton et al., 2013). In contrast, co-expression of
another b chain, Integrin-b2 (Mesp>Intb2), restores founder cell
adhesion and heart progenitor induction in Mesp>RapS17N
foundercells (as illustrated inFigure2A0;Nortonet al., 2013).Usingevier Inc.
the FGFR:Venus assay, we found that Integrin-b chains have a
similar, selective impact on FGFR enrichment. Mesp>Intb1 failed
to restore receptor enrichment in transgenic Mesp>RapS17N
founder cells (Figure 2E). Mesp>Intb2, on the other hand, led to
a robust and significant restoration of FGFR enrichment (arrows,
Figure 2F). Strikingly, Intb2-dependent restoration of FGFR
enrichment occurs in a similar proportion of embryos (82.6% ±
1.9%, SEM) as Intb2-dependent restoration of induction
(75.8% ± 1.2%, SEM; observed previously Norton et al., 2013).
Thus, rescuing matrix adhesion is sufficient to restore localized
FGFR enrichment and differential induction.
We further examined the proposed sufficiency of matrix adhe-
sion in FGFR enrichment by transfecting embryos with a consti-
tutively active Rap construct, Mesp>RapG12V and examining the
impact on FGFR:Venus distribution. Previously, we have shown
that expression of RapG12V in cardiac founder cells results in
enhanced matrix adhesion and increased heart progenitor in-
duction (as illustrated in Figure 2A0 0; Norton et al., 2013). During
mitosis, Mesp>RapG12V transgenic founder cells are flattened
along the ventral epidermal boundary, presumably reflecting
their increased adhesion to the epidermal matrix (cf. Figure 2G
to Figure 2B). Increased adhesion is mirrored by a dramatic
and significant enhancement of FGFR:Venus staining both inter-
nally and along the expanded adherent ventral membrane
(cf. Figure 2G0 to Figure 2B0). In mitotic control cells, FGFR:Venus
is associated with the plasma membrane along approximately
19% of the founder cell periphery (Figures 2B0 and 2H). In mitotic
RapG12V cells, FGFR:Venus is associated with the membrane
along 40% of the founder cell periphery (Figures 2G0 and 2H).
In post-mitotic RapG12V cells, FGFR:Venus is present in both
daughter cells (data not shown). Taken together, these data
show that matrix adhesion is both necessary and sufficient for
localized FGFR enrichment, strongly supporting the core prem-
ise of our ‘‘adhesive enrichment’’ model.
Selective Restoration of FGF Receptor Enrichment by
Integrin-b2
We next began to explore the adhesive enrichment model
through comparative, functional analysis of Ciona Integrin-b
chains. Integrin b1 and b2 are highly divergent proteins with
distinct N-terminal extracellular domains conferring matrix bind-
ing specificity and distinct C-terminal cytoplasmic domains
conferring discrete signal transduction properties (Liu et al.,
2000). Because Integrin b2 selectively inhibits mitotic FGF recep-
tor internalization, we hypothesized that b2-specific domains
regulating internalization would be more relevant than either
matrix binding or signal transduction domains. In particular, we
focused on conserved variations within well-characterized
C-terminal NPxX motifs (Figures 3A and 3B; Caswell et al.,
2009; Moser et al., 2009). Previous studies suggest that NPxY
phosphorylation regulates integrin activity and trafficking (Anthis
et al., 2009; Pellinen et al., 2008). Clathrin adaptors, including
DAB and NUMB, bind NPxX motifs to regulate Integrin endocy-
tosis (Nishimura and Kaibuchi, 2007; Teckchandani et al., 2009).
In b1 family Integrins, the distal motif includes a tyrosine (NPxY),
while in b2 family Integrins it does not (NPxF; Figures 3A and 3B;
Calderwood et al., 2003). Replacement of Intb1 NPxX tyrosine
residues with phenylalanines (b1YYFF) decreased endocytosis
and inhibited focal adhesion turnover (Pellinen et al., 2008). WeDevelopmenreasoned that selective restoration of induction by Intb2 in
RapS17N founder cells might reflect decreased internalization of
adherent membranes conferred by the absence of tyrosine res-
idues in the b2 tail motif (Figure 3A). To test this hypothesis, we
introduced a Y>F amino acid substitution into the distal NPxY
motif of the Integrin-b1 cytoplasmic tail, rendering this motif
non-phosphorylatable (Mesp>Intb1Y694F; Figure 3B). We also
introduced the reciprocal F>Y substitution in Integrin-b2
(Mesp>Intb2F801Y; Figure 3B). The mutated b chain constructs
were then co-transfected with Mesp>RapS17N and FoxF>RFP.
Remarkably, these single amino acid substitutions were
sufficient to completely reverse b chain-specific restoration of
heart progenitor induction. Co-expression of non-phosphorylat-
able Intb1Y694F rescued heart progenitor induction; producing
results indistinguishable from those observed for Mesp>Intb2
(Figures 3D–3F and 3J; Figure S2). Conversely, co-transfection
with phosphorylatable Intb2F801Y failed to rescue induction,
producing results indistinguishable from those observed for
Mesp>Intb1 (Figures 3G–3J; Figure S2). We also tested whether
mutated b chain constructs were able to restore matrix
adhesion, using an established ex vivo assay (Norton et al.,
2013). Consistent with the presumed impact on mitotic internal-
ization; introduced mutations reversed b chain-specific restora-
tion of heart progenitor adhesion. Expression of Intb1Y694F
restored heart progenitor adhesion in cells co-transfected with
Mesp>RapS17N; producing results similar to those observed for
Mesp>Intb2 (cf. Figure 3C to Figure 6E and Norton et al.,
2013). Conversely, co-transfection with Intb2F801Y failed to
restore adhesion, producing results similar to those observed
for Mesp>Intb1 (Figure 3C; Norton et al., 2013).
Molecular crosstalk between Integrins and growth factor
signaling occurs onmultiple levels. Integrin-dependent remodel-
ing of the extracellular matrix can impact the distribution and
availability of ligands including FGF (Kim et al., 2011). Integrin
and growth factor receptor complexes also activate overlapping
cytoplasmic signal cascades (Legate et al., 2009). Furthermore,
Integrin activation promotes local changes in plasma membrane
composition and underlying cortical domains thereby impacting
growth factor receptor trafficking and/or compartmentalization
(Ivaska and Heino, 2011). Our mutational analysis demonstrates
that b chain-specific impacts on induction arise solely fromdiffer-
ences in the cytoplasmic NPxXmotif. Thus, b chain-specific ma-
trix binding or cytoplasmic signaling properties do not account
for the observed differences in their inductive potential. Along
these lines, targeted expression of constructs designed to
disrupt Integrin-dependent signal transduction (Delcommenne
et al., 1998; Shibue and Weinberg, 2009), including dominant-
negative Integrin-linked Kinase (Mesp>ILKDN) or Focal Adhesion
Kinase (Mesp>FRNK), had no impact on heart progenitor induc-
tion (data not shown). Taken together, these results suggest that
adhesion primarily impacts heart progenitor induction by altering
membrane dynamics, suppressing mitotic internalization of
FGFR-enriched membranes and subsequent degradation.
FGF Receptor Enrichment and Heart Progenitor
Induction Are Increased by Perturbing Receptor
Degradation
To begin investigating the proposed role of degradation in adhe-
sion-dependent FGFR enrichment, we attempted to perturb thetal Cell 34, 505–519, September 14, 2015 ª2015 Elsevier Inc. 509
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Figure 3. Selective Restoration of FGF Receptor Enrichment by Intb2 Is Dependent on Conserved NPxF Motif
(A) Proposed model for Intb2-specific rescue of founder cell adhesion and heart progenitor induction.
(B) ClustalW alignment of C. intestinalis Intb1 and Intb2 cytoplasmic tail domains. Proximal NPxF motifs (orange) and distal NPxY/F motifs (blue) as well as amino
acid substitutions (red) are indicated.
(C) Adhesion ratio of dissociated transgenic founder cells plated on Fibronectin (normalized tomean levels of adhesion in RapS17N cells). Data were obtained from
three independent trials. *p = 0.236 (n.s.) for LacZ versus Intb2F801Y, 0.013 for LacZ versus Intb1Y694F and 0.002 for Intb2F801Y versus Intb1Y694F.
(D–I) Representative micrographs showing heart progenitor induction (FoxF>RFP, arrowheads) versus non-induced founder lineage cells (Mesp>GFP alone,
arrows) in embryos co-transfected as indicated.
(legend continued on next page)
510 Developmental Cell 34, 505–519, September 14, 2015 ª2015 Elsevier Inc.
degradation pathway and examine the impact on FGFR:Venus
distribution. Previous studies have demonstrated that applica-
tion of the proteasome inhibitor MG132 provides a crude but
effective strategy for inhibiting FGFR degradation (Bonaventure
et al., 2007; Hatch et al., 2006; Kaabeche et al., 2004; Monso-
nego-Ornan et al., 2002). We therefore treated transgenic
embryos (Mesp>RapS17N, Mesp>FGFR:Venus, + Mesp>LacZ)
with MG132 or with the carrier solution (DMSO) for 1 hr prior to
the onset of founder cell division and examined FGFR:Venus
staining. The majority of DMSO treated RapS17N founder cells
displayed a complete loss of FGFR:Venus staining (Figures 4A
and 4C). MG132 treatment dramatically reversed this trend,
significantly increasing the proportion of FGFR:Venus positive
founder cells in RapS17N transgenic embryos (Figures 4B and
4C). In addition, we found that MG132-treatment restored
normal heart progenitor induction in a significant proportion of
Mesp>RapS17N transgenic embryos (Figure 4D; Figures S3A–
S3D). Furthermore, MG132 treatment of Mesp>LacZ control
embryos was sufficient to generate a small but significant pro-
portion of embryos displaying enhanced induction (Figure 4D).
These results suggest that differential heart progenitor induction
involves regional, adhesion-dependent suppression of FGFR
degradation.
Correlation between Caveolin and FGFR Distribution
during Founder Cell Mitosis
To further investigate the molecular link between adhesion and
mitotic membrane turnover, we focused our analysis on Caveo-
lin. Caveolins are integral membrane proteins that modulate
plasma membrane compartmentalization, curvature, and inter-
nalization (Parton and del Pozo, 2013). Published microarray
data indicate that the Ciona Caveolin-1 ortholog, Ci-CavA
(referred to hereafter as Caveolin), is highly expressed in founder
lineage cells (Woznica et al., 2012). Caveolin-rich membrane do-
mains (CRMs) function as scaffolds for signaling complexes
(Parton and del Pozo, 2013; Zhou et al., 2014). Although CRMs
have not been explicitly linked to FGF receptor trafficking, previ-
ous studies have documented Caveolin-regulated trafficking of
related growth factor receptors (Di Guglielmo et al., 2003; Stra˚l-
fors, 2012). Adhesion complexes are also known to inhibit CRM
internalization (del Pozo et al., 2004; Stra˚lfors, 2012). Thus, it has
been proposed that adhesive maintenance of Caveolin-associ-
ated signaling domains underlies anchorage-dependent growth
(Di Guglielmo et al., 2003; Du et al., 2011; Guadamillas et al.,
2011; Schmidt-Glenewinkel et al., 2012). These findings promp-
ted us to explore whether Caveolin contributes to adhesion-
mediated enrichment of FGFR.
We first examined whether there is any correlation between
the localization of CRM domains and FGFR during mitosis.
To monitor CRM distribution, we expressed a Caveolin:GFP
fusion protein in founder cells using the Mesp driver (Mesp>
Caveolin:GFP) and examined staged embryos spanning founder
cell mitosis. In pre-mitotic founder cells, Caveolin:GFP is heavily(G–I) Data were obtained from three independent trials, n > 31/trial. p values com
0.001 for RapS17N versus Intb2, 0.003 for RapS17N versus Intb1Y694F and 0.013 fo
(J) Quantitative analysis of induction data. Two of four FoxF>RFP positive founder
positive cells was scored as ‘‘reduced induction.’’
Significance was determined using a two-tailed unpaired t test. Scale bars are ind
Developmenenriched along the ventral founder cell membrane (Figure 4E).
Consistent with studies in mammalian epithelial cell lines
(Boucrot et al., 2011; del Pozo et al., 2005), the majority of
Caveolin:GFP appears to be internalized during mitosis (Fig-
ure 4F). However, as observed with FGFR:Venus, both mem-
brane-associated and intracellular Caveolin:GFP is differentially
enriched on the ventral side of dividing heart founder cells (Fig-
ure 4F). Quantification of membrane-associated Caveolin:GFP
fluorescence confirms that the observed ventral enrichment is
consistent and significant (VMem/DMem = 2.83 ± 0.43, VInt/DInt =
2.62 ± 0.10; Figure 4F0). After division, Caveolin:GFP is highly
concentrated in the newly formed heart progenitors (Figure 4G).
Thus, Caveolin:GFP and FGFR:Venus share similar distribution
patterns (cf. Figures 1 and 4). To better evaluate the apparent
confluence between Caveolin and FGFR localization patterns
in mitotic founder cells, we generated transgenic embryos co-
expressing FGFR:Venus and Caveolin:RFP. In these double
transgenic founder cells, a partially overlapping distribution
pattern along the ventral, adherent membrane was evident (Fig-
ures S3H and S3I).
Matrix Adhesion Is Required for Mitotic Caveolin
Distribution
We next examined whether matrix adhesion is required for
maintenance of CRMs during founder cell mitosis. For this
purpose, we inhibited matrix adhesion through targeted
expression of RapS17N and examined the impact on Caveolin:
GFP distribution. Disrupting adhesion had a dramatic impact
on Caveolin:GFP distribution (Figures 4H, 4I, S3F, and S3G).
In fully detached mitotic founder cells, Caveolin:GFP mem-
brane enrichment was abrogated, replaced by staining in
intracellular foci (Figure 4I). In partially detached founder cells,
Caveolin:GFP staining persisted along adherent membranes
(Figure 4H). Thus it appears that Caveolin:GFP internalization
during mitosis is inhibited along adherent membranes, mirror-
ing the pattern observed for FGFR:Venus (Figures 1B–1D).
These results indicate that localized matrix adhesion promotes
mitotic retention of CRMs (Figures 4J and 4J0), in accordance
with published observations in mammalian cells (del Pozo
et al., 2005).
Caveolin-Rich Membrane Domains Are Required for
FGFR Enrichment and Heart Progenitor Induction
We next focused on determining whether CRMs are required for
differential, mitotic FGFR enrichment. For this purpose, we car-
ried out targeted mutagenesis of Ciona Caveolin (CavA) using
a tissue-specific CRISPR/Cas9 expression construct (Stolfi
et al., 2014). Guide RNAs targeting exon 1 of Caveolin (Fig-
ure 5C) were cloned into the previously characterized Ciona
U6>sgRNA(F+E) vector (U6>CavA.39 gRNA, Table S1; Stolfi
et al., 2014). To control for potential off-target effects, we intro-
duced single base mismatches in the U6>CavA.sgRNA con-
structs (Table S1; Sasaki et al., 2014). To assay their impact onparing percentage of normal induction, *p = 0.0002 for LacZ versus RapS17N,
r Intb2 versus Intb2F801Y. Error bars represent the SEM in (C) and (J).
lineage cells was scored as ‘‘normal induction’’ (D–F). Less than two FoxF>RFP
icated inmicrometers. Embryos oriented anterior to the left. See also Figure S2.
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Figure 4. Matrix Adhesion Is Required for Mitotic CRM Enrichment during Heart Progenitor Induction
(A–C) Lateral sections showing representative FGFR:Venus staining in RapS17N transgenic founder cells treated with DMSO (A) or MG132 (B) and
graphical summary (C) of FGFR staining in LacZ control and RapS17N transgenic founder cells treated as indicated. Data were obtained from two independent
trials, n > 44/trial. *p = 0.005.
(D) Graphical summary of induction data. Data were obtained from three independent trials, n > 29/trial. Error bars represent the SEM. *p = 0.030 for increased
induction in LacZ+DMSO versus LacZ+MG132 and 0.037 for normal induction in RapS17N+DMSO versus RapS17N+MG132. Significance was determined using a
two-tailed unpaired t test in (C and D).
(E–I0 0) Lateral sections and accompanying diagrams of Mesp>Caveolin:GFP distribution in mitotic founder cells co-transfected as labeled. Dashed lines indicate
phalloidin stained cell membranes (red) or epidermal border (white, Epi). Membrane-associated Caveolin:GFP foci are indicated (arrows).
(legend continued on next page)
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FGFR trafficking, Caveolin gRNAs were co-electroporated with
Mesp>nls::Cas9::nls and Mesp>FGFR:Venus. FGFR distribution
in mitotic founder cells co-transfected with the mismatch control
construct (Mesp>nls::Cas9::nls + U6>CavA.39 gRNAmm2) ap-
peared identical to control embryos, displaying clear FGFR
enrichment along the ventral membrane (cf. Figure 5A to Fig-
ure 1C). In contrast, co-transfection with the matching sgRNA
(Mesp>nls::Cas9::nls + U6>CavA.39 gRNA) abrogated polarized
FGFR:Venus enrichment in 31.3% of mitotic founder cells (Fig-
ure 5B). To verify that the observed defects in FGFR trafficking
were associated with mutagenesis of Caveolin, we amplified
and sequenced the presumed CRISPR target region in exon 1.
In transgenic embryonic samples, mutations specific to the tar-
geted region occurred in 25% (2/8) of exonic sequences (Fig-
ure 5D). We also investigated the impact of Caveolin knockdown
on differential heart progenitor induction. In CRISPR mismatch
controls (Mesp>nls::Cas9::nls + U6>CavA.39 gRNAmm), we
consistently observed the wild-type induction pattern (Figures
5E, 5G, and S4C) at levels indistinguishable from typical loading
controls (cf. Figures 5E and 5G to Figures 3D and 3J). In contrast,
19% of transgenic Mesp>nls::Cas9::nls + U6>CavA.39 gRNA
embryos displayed reduced induction (p < 0.0002 and p <
0.044; Figures 5F, 5G, and S4D). Our sequence analysis (Fig-
ure 5D) indicates that low penetrance of the reduced induction
phenotype associated with Caveolin CRISPR may be due to
limited mutagenesis, perhaps reflecting the extremely short win-
dow (1.5 hr) between the initial onset of Mesp-driven Cas9
expression and FGF-dependent heart progenitor induction. To
produce a more robust disruption of Caveolin-enriched mem-
branes, we also employed a dominant-negative approach. This
involved targeted expression of the P189L Caveolin mutant
(Mesp>CaveolinP189L:GFP). Ciona CaveolinP189L is analogous
to human Caveolin 1P132L, a mutation that disrupts CRM forma-
tion by sequestering endogenous Caveolin in theGolgi body (Lee
et al., 2002; Shatz et al., 2010). We first assayed the impact of
CaveolinP189L on FGFR distribution through co-transfection
with Mesp>FGFR:Venus. In control mitotic founder cells, we
consistently observed the wild-type enrichment pattern (Fig-
ure S3I). In contrast, CaveolinP189L expression abrogated ventral
FGFR enrichment (Figure S3K). We next assayed the impact of
CaveolinP189L on heart progenitor induction. Mesp>Caveolin:
GFP control embryos consistently displayed the wild-type in-
duction pattern (Figures 5H, 5J, and S4E). Strikingly, over 75%
of Mesp>CaveolinP189L:GFP transgenic embryos displayed
complete loss of induction, as evidenced by the absence of
FoxF>RFP and associated heart progenitor migration (Figures
5I, 5J, and S4F). The severe impact of dominant-negative
Caveolin on induction closely parallels the levels of reduced
induction seen upon disruption of matrix adhesion (Mesp>
RapS17N; Figure 3J; Norton et al., 2013). Taken together, these
results indicate that Caveolin is required for localized FGFR
enrichment within adherent membranes (Figures 5K and 5K0).
However, they do not address whether Caveolin functions up-
stream or downstream of adhesion.(J and J0 ) Proposedmodel for adhesion-dependent enrichment of Caveolin and he
current results and previous data (Norton et al., 2013). Adhesive foci (yellow), CRM
ATM, anterior tail muscle cell. Scale bars are indicated in micrometers. Embryos
See also Figure S3.
DevelopmenCaveolin-Rich Membrane Domains Promote Differential
Induction Downstream of Adhesion
To begin investigating the epistatic relationship between matrix
adhesion and CRMs, we expressed Caveolin (Mesp>Caveolin:
GFP) in founder cells co-transfected with Mesp>RapS17N. Tar-
geted RapS17N does not completely disrupt matrix adhesion,
as illustrated by the maintenance of partial attachment in some
RapS17N founder cells (Figure 2D; Norton et al., 2013). Therefore,
transgenic RapS17N founder cells provide a sensitized back-
ground to explore adhesive founder cell polarization. Remark-
ably, co-transfection with Mesp>Caveolin:GFP generated a
consistent and significant rescue of heart progenitor induction
(Figures 6A–6D and S5). This result suggests that residual adhe-
sion in RapS17N transgenic founder cells is sufficient for mitotic
recruitment or retention of overexpressed Caveolin, thereby
restoring differential induction (Figures 6F and 6F0). We were
intrigued to find that rescued FoxF>RFP positive heart progen-
itors remained in the tail region, adjacent to their sister cells
(arrowheads, Figure 6C). The apparent lack of heart progenitor
migration in these assays suggested that Caveolin expression
restored induction while failing to replenish matrix adhesion.
We examined this hypothesis directly by measuring matrix
adhesion of dissociated founder cells. As previously demon-
strated (Norton et al., 2013), co-expression of Intb2 re-estab-
lishes matrix adhesion in the RapS17N background (Figure 6E).
Co-expression of Caveolin:GFP, on the other hand, had no
impact on founder cell adhesion (Figure 6E). Thus, targeted
expression of Caveolin is sufficient to restore inductive
signaling even when matrix adhesion is compromised. Taken
together, these results indicate that CRMs function down-
stream of adhesion to polarize mitotic FGFR distribution and
inductive signaling.
DISCUSSION
A Revised Model for Polarized Heart Progenitor
Induction in Ciona
Collectively, our data support a revised model for heart progen-
itor induction (Figure 7). According to this model, invasive
founder cell protrusions promote adhesive anchoring along the
underlying epidermis. Anchored adhesions are differentially
maintained during mitotic rounding (Figure 7C; Cooley et al.,
2011; Norton et al., 2013). Within anchored membranes, Integrin
complexes promote retention of Caveolin-rich membrane do-
mains and associated FGF receptors during mitotic membrane
turnover (Figure 7C0). Retention may reflect either decreased
endocytosis or increased recycling of FGFR-enriched mem-
branes. Within non-adherent membranes, CRMs and FGF re-
ceptors are internalized and either degraded or trafficked toward
the adherent membrane (Figure 7C0 0). Subsequently, FGFR-en-
riched adherent membranes or associated vesicles are inherited
by heart progenitor cells, driving differential induction (Figure 7D).
Our revised model has implications regarding the roles of
adhesion, Caveolin and mitotic membrane turnover in receptorart progenitor induction in LacZ and RapS17N transgenic founder cells based on
s (red). Heart progenitor induction indicated by red nuclei. HP, heart progenitor;
are oriented anterior to the left. Embryos oriented anterior to the left.
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Figure 5. Caveolin Is Necessary for Mitotic FGFR Retention and Heart Progenitor Induction
(A–B0 0 ) Lateral sections and accompanying diagrams of FGFR:Venus distribution in mitotic founder cells co-transfected as labeled. Membrane-associated
FGFR:Venus foci are indicated (arrows). Dashed lines indicate phalloidin stained cell membranes (red) or epidermal border (white, Epi).
(C) Ciona intestinalis CavA gene, showing exons (solid boxes) and introns. Approximate locations of gRNA target sequences in exon 1 are indicated.
(D) Alignment of CavA alleles cloned from pooled embryos electroporated with Mesp>nls::Cas9::nls and U6>CavA.39 gRNA.
(E, F, H, and I) Representative micrographs showing heart progenitor induction (FoxF>RFP, arrowheads) versus non-induced founder lineage cells (Mesp>GFP
alone, arrows) in embryos co-transfected as indicated.
(G) Graphical summary of CRISPR/CAS9 induction data. Data were obtained from two independent trials, n > 41/trial. Error bars represent the SEM. *p = 0.044 for
U6>CavA.39sgRNA mismatch (control) versus U6>CavA.39sgRNA.
(J) Graphical summary of CaveolinP189L (dominant-negative) induction data. Data were obtained from three independent trials, n > 25/trial. Error bars represent
the SEM. *p = 0.000007 for Caveolin:GFP versus CaveolinP189L. Significance was determined using a two-tailed unpaired t test.
(K and K0) Proposedmodel for CRM-dependent FGFR enrichment and differential heart progenitor induction in control and Caveolin-deficient transgenic founder
cells. CRMs (red); FGFRs (green). Heart progenitor induction is indicated by red nuclei. HP, heart progenitor; ATM, anterior tail muscle cell; Epi, ventral epidermis.
Scale bars are indicated in micrometers. Embryos oriented anterior to the left. See also Figure S4.
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Figure 6. Caveolin Functions Downstream
of Adhesion during Heart Progenitor
Induction
(A–C) Representative micrographs showing heart
progenitors (FoxF>RFP, arrowheads) versus non-
induced founder lineage cells (Mesp>GFP alone,
arrows) in embryos co-transfected as indicated.
(D) Graphical summary of induction data. Data
were obtained from three independent trials,
n > 22/trial. *p = 0.003 for LacZ versus RapS17N
and 0.040 for RapS17N versus Caveolin:GFP.
(E) Adhesion ratio of dissociated transgenic
founder cells plated on Fibronectin. Data were
obtained from two independent trials. *p = 0.021
for RapS17N versus Intb2. Error bars represent the
SEM in (D) and (E). Significance was determined
using a two-tailed unpaired t test.
(F and F0) Proposed model for Caveolin-depen-
dent rescue of differential heart progenitor induc-
tion in RapS17N deficient transgenic founder cells.
Residual adhesive foci are indicated (yellow bars);
CRMs (red). Heart progenitor induction is indi-
cated by red nuclei.
HP, heart progenitor; ATM, anterior tail muscle
cell. Scale bars are indicated in micrometers.
Embryos oriented anterior to the left. See also
Figure S5.trafficking, anchorage-dependent growth and asymmetric fate
specification as discussed below.
Caveolin-Dependent Modulation of Receptor
Trafficking
Our findings coincide with previous observations regarding po-
tential contributions of CRMs to FGFR trafficking. In zebrafish
embryos, ubiquitin-dependent co-localization of Caveolin and
FGFR1 is associated with formation of FGF morphogen gradi-
ents (Nowak et al., 2011). In addition, Bryant et al. demonstrated
that phosphorylated FGFR2 localizes to Caveolin-rich mem-
brane fractions in oligodendrocytes and that this localization is
necessary for the activation of downstream signaling (Bryant
et al., 2009). Our results indicate that CRMs also suppress the
mitotic turnover of FGF receptors in Ciona cardiac founder line-
age cells. However, the precise impact of CRMs on receptor traf-
ficking remains poorly delineated. Amore refinedmodel requires
characterization of relevant CRM-dependent effectors. Further
analysis will also focus on determining whether CRMs suppress
FGFR turnover by inhibiting endocytosis or facilitating recycling.
In addition, we intend to investigate whether CRMs modulate
FGFR trafficking primarily through Clathrin-dependent or inde-
pendent pathways. Furthermore, our previous research indi-
cates that cytoskeletal dynamics associated with invasive
protrusions are associated with differential induction. We are
therefore interested in exploring the potential interplay between
invasive protrusions, CRMs and mitotic receptor turnover. Ulti-
mately, high-resolution in vivo analysis will be required to
address many of these questions, delineating how CRM-depen-
dent alterations of lipid composition, vesicle trafficking, and
cytoskeletal dynamics are integrated to promote polarized
FGFR distribution.DevelopmenDifferential Induction through Adhesion-Dependent
Partitioning of Caveolar Signaling Domains
Our findings illustrate how three established properties of adhe-
sive membrane organization can synergize in an unanticipated
manner to promote differential induction. First, Integrins are
known to modulate trafficking of Receptor Tyrosine Kinases
(RTKs) and other growth factor receptors (Ivaska and Heino,
2011). Second, CRM-dependent compartmentalization of sig-
naling pathway components is well established (Harvey and
Calaghan, 2012; Patel et al., 2008). Third, multiple studies have
characterized adhesion-dependent suppression of Caveolin
turnover (del Pozo et al., 2004; Radel and Rizzo, 2005; Singh
et al., 2007; Wickstro¨m et al., 2010). Indeed, CRM internalization
is considered central to anchorage-dependent growth, ensuring
termination of signaling in detached cells (Cerezo et al., 2009; del
Pozo et al., 2005; Salanueva et al., 2007). These three properties
are not considered specialized, cell-type-specific aspects of
adhesive membrane dynamics. Rather, they are thought to
reflect fundamental cellular processes. Thus, the adhesion-
dependent polarization of caveolar signaling domains central
to our model may represent a widespread mechanism for differ-
ential induction.
Mitosis as an Orchestrator of Adhesive Signal
Compartmentalization
Our revised model also suggests that membrane turnover, an
inherent property of cell division, can orchestrate differential in-
duction. During mitosis, dramatic changes in surface area are
driven by regional alterations in membrane trafficking (Boucrot
and Kirchhausen, 2007; Montagnac et al., 2008). Shifts in endo-
cytic recycling rates promote initial membrane uptake and
subsequent re-distribution during anaphase and cytokinesistal Cell 34, 505–519, September 14, 2015 ª2015 Elsevier Inc. 515
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Figure 7. Revised Model of Adhesion-
Dependent Heart Progenitor Induction
(A–D) Diagrams illustrating adhesion-dependent
variation in receptor enrichment and trafficking
during founder cell mitosis. See also Figure S6.(Boucrot and Kirchhausen, 2007). A recent study highlighted the
role of mitotic membrane turnover in re-establishing planar cell
polarity (Shrestha et al., 2015). Additionally, mitotic membrane
turnover encompasses Caveolin-rich domains. Caveolin-en-
riched vesicles are internalized during mitotic rounding and
recycled back to the plasmamembrane during cytokinesis (Bou-
crot et al., 2011). Mitotic CRM redistribution in symmetrically
dividing cells is thought to ensure uniform distribution of Caveo-
lin and associated signaling domains (Figure S6A0; Boucrot et al.,
2011). Our data indicate that regionalized adhesion can break
the inherent symmetry of mitotic Caveolin trafficking, resulting
in polarized CRM distribution (Figure S6A0 0). Because CRMs
facilitate receptor enrichment, mitotic CRM polarization drives
asymmetric fate specification.
Our model also highlights an unanticipated, regulatory role for
mitosis in adhesive signaling. According to current paradigms,
mitosis is considered a regulatory target, modified by upstream
asymmetries in adhesion (LaFlamme et al., 2008; Streuli, 2009).
For example, stem cell niche adhesion regulates mitotic spindle
orientation. The resulting shift in division plane indirectly regu-
lates signal polarization by orienting cells within the niche (Gou-
las et al., 2012; Yamashita et al., 2010). Our findings shift this
perspective, indicating that mitosis plays a direct, regulatory
role in adhesion-dependent signal polarization. According to
our model, the majority of adhesive foci are disassembled during
mitotic rounding, leaving behind a regionally enriched adhesive
domain. Subsequently, mitotic membranemobilization redistrib-
utes CRM signaling platforms in accordance with newly estab-
lished adhesive polarity (Figure S6). Thus, mitotic rounding
functions as a threshold filter, promoting signal polarization by
removing weak adhesions and thereby attenuating uniform
adhesive ‘‘noise.’’ Mitoticmembranemobilizationmay also func-
tion as an amplifier, enhancing polarized adhesive signaling
through biased re-distribution of Caveolin-rich membrane com-
partments. According to this paradigm, mitosis and adhesive516 Developmental Cell 34, 505–519, September 14, 2015 ª2015 Elsevier Inc.signaling participate in a feedback loop
that may coordinate asymmetric out-
comes during embryonic patterning and
stem cell division.
EXPERIMENTAL PROCEDURES
Embryonic Techniques
Ciona intestinalis were supplied by M-Rep. Fertil-
ization, staging, dechorionation, and electropora-
tion were carried out as previously described
(Cooley et al., 2011; Corbo et al., 1997).
Molecular Cloning
The Ci-Mesp and FoxF enhancers were described
previously (Beh et al., 2007; Davidson et al., 2005).
The RapS17N, Intb1 and Intb2 constructs were
described previously (Norton et al., 2013). TheMesp>Intb1Y694F and Mesp>Intb2F801Y mutant constructs were generated by
site-directed mutagenesis of the Mesp>Intb1 and Mesp>Intb2 expression
plasmids. Mesp>FGFR:Venus was sub-cloned from a Brac>FGFR:Venus
construct generously provided by Weiyang Shi. The full-length coding region
of FGFR was initially amplified from EST clone GC32j14 (Ciona intestinalis
Gene Collection Release 1; Beh et al., 2007; Satou et al., 2002) and inserted
downstream of the Brachyury enhancer using Not1 and EcoR1. The Venus
open reading frame (ORF) was then fused in frame using the EcoR1 site.
FGFR:Venus was subsequently sub-cloned downstream of the Mesp
enhancer using XbaI and Not1 sites. Ci-Caveolin (CavA) was PCR amplified
from the full open reading frame unigene collection (Cogenics) clone
id# VES60_PO7 and inserted into either Mesp>GFP or Mesp>RFP fusion vec-
tors. The Mesp>Caveolin mutant constructs were generated by site-directed
mutagenesis of the Mesp>Caveolin expression plasmid.
Antibody Staining and Image Analysis
Embryos were fixed and antibody stained as previously described (Cooley
et al., 2011) using the following antibodies: rabbit anti-GFP (catalog no.
A-11122; Life Technologies), mouse anti-GFP (catalog no. A-11120; Life Tech-
nologies), rat anti-RED (catalog no. ABIN334653; Antibodies Online), Alexa
Fluor 488 anti-mouse (catalog no. A21202; Molecular Probes), Alexa Fluor
488 anti-rabbit (catalog no. A21206; Molecular Probes), Alexa Fluor 564 anti-
rat (catalog no. A-21208; Molecular Probes). Alexa Fluor Phalloidin 555/633
(Molecular Probes) was used to detect F-actin. DRAQ5 (Molecular Probes)
was used to detect DNA. For measurements of ventral/dorsal staining ratios,
lateral optical section obtained from 1-mM confocal stacks were analyzed
using ImageJ. Generation and use of the region of interest (ROI) and back-
ground subtraction tools achieved consistent outlining and detection of
GFP-stained regions.
CRISPR/Cas9
U6>sgRNA(F+E) and Mesp>nls::Cas9::nls plasmids were a kind gift of Lionel
Christiaen (Stolfi et al., 2014). Putative (N21)+GG exon 1 CavA gRNA targets
were identified with Jack Lin’s CRISPR/Cas9 gRNA Finder (http://spot.
colorado.edu/slin/cas9.html) and subsequently screened for off-targets
and polymorphisms. gRNAs were inserted in to the empty U6>sgRNA(F+E)
plasmid by inverse PCR. Single base mismatch mutations were introduced
by site-directed mutagenesis. To assess mutagenesis of CavA, we amplified
the presumed CRISPR target region in exon 1 using genomic DNA isolated
from pooled transgenic embryos (n > 100). Targeted Caveolin genomic DNA
was amplified and cloned into pCRII-TOPO Dual-Promoter (Invitrogen) prior to
sequencing.
Ex Vivo Adhesion Assays
All assays were performed as described previously (Norton et al., 2013). The
raw average values ±SEM are as follows (adherent cells::estimated cell
density 3 105): RapS17N Control: 28.3.4 ± 8.7::0.63 ± 0.28; RapS17N +
Intb1Y694F: 51.7 ± 7.4::0.71 ± 0.26; RapS17N + Intb2F801Y: 39.7 ± 13.7::0.82 ±
0.07 (Figure 3C) and RapS17N Control: 15.5 ± 1.7::2.2 ± 0.76; RapS17N +
Intb2 Control: 14 ± 0.59::1.73 ± 0.74; RapS17N + Caveolin:GFP: 20.5 ±
0.94::4.4 ± 1.9 (Figure 6E).
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